← Eichor
Study identifier: NCT05765656 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly

Condition: Primary Care · Health Plan Implementation · Benzodiazepine Dependence  ·  Sponsor: Nantes University Hospital

PhaseNA
Planned participants400
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

Benzodiazepines or related drug (BZDR) are consumed for hypnotic or anxiolytic purposes in most cases. The consequences of BZDR are multiple with an increased risk of daytime sedation, balance disorders leading to falls and fractures, cognitive disorders, road accidents and dementia. Given their comorbidities, physiological changes, and multiple medications, the elderly are more at risk of suffering from BZDR adverse events. Interprofessional collaboration has shown efficacy in improving prescribing appropriateness and may affect patients outcomes positively. Morever, motivational interviews (MI) may reduce the extent of substance abuse compared to no intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Jean-François HUON, Pharm.D PhD  ·  0244768074  ·  jeanfrancois.huon@chu-nantes.fr

Jean-Pascal Fournier, Professor  ·  jean-pascal.fournier@univ-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de NantesNantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05765656